Aclaris Therapeutics, Inc. is a specialty pharmaceutical company focused on the development of a topically applied therapy directed toward the removal of seborrheic keratosis (SK) and other verrucoid lesions of the skin.


Patents show all


Clinical Trials show all

9Phase 23Phase 31Phase 1/Phase 2

SEC Filings show all



Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2014-10-02$21,000,000Series BSofinnova Ventures, F-Prime Capital Partners, Vivo Capital
2015-09-09$40,000,000Series CRA Capital ManagementAperture Venture Partners, Mossrock Capital, Cormorant Asset Management, Sofinnova Ventures, Vivo Capital, Rock Springs Capital, F-Prime Capital Partners
2012-10-24$21,000,000Series AVivo Capital, F-Prime Capital PartnersSofinnova Ventures
2016-06-14$20,000,017Post Ipo EquityAisling Capital